Alport Syndrome clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)
Sorry, in progress, not accepting new patients
This study is a proof-of-concept trial of vonafexor safety, its effects on kidney function in subjects with at risk of progression Alport syndrome.
Los Angeles 5368361, California 5332921 and other locations
Our lead scientists for Alport Syndrome research studies include Anjay Rastogi, MD, PhD.